{"altmetric_id":3358985,"counts":{"readers":{"mendeley":25,"citeulike":0,"connotea":0},"total":{"posts_count":1},"wikipedia":{"unique_users_count":1,"unique_users":["en:4269861"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa4f53cf058f610002e47","authors":["George D. Hartman","Melissa S. Egbertson","Wasyl Halczenko","William L. Laswell","Mark E. Duggan","Robert L. Smith","Adel M. Naylor","Patricia D. Manno","Robert J. Lynch"],"doi":"10.1021\/jm00102a020","endpage":"4642","first_seen_on":"2015-02-05T20:07:11+00:00","issns":["0022-2623","1520-4804"],"issue":"24","journal":"Journal of Medicinal Chemistry","last_mentioned_on":1229315784,"links":["http:\/\/dx.doi.org\/10.1021\/jm00102a020","http:\/\/dx.doi.org\/10.1021%2Fjm00102a020"],"pubdate":"1992-11-01T00:00:00+00:00","publisher_subjects":[{"name":"Medicinal And Biomolecular Chemistry","scheme":"era"},{"name":"Pharmacology And Pharmaceutical Sciences","scheme":"era"},{"name":"Organic Chemistry","scheme":"era"}],"scopus_subjects":["Life Sciences","Pharmacology, Toxicology and Pharmaceutics","Biochemistry, Genetics and Molecular Biology"],"startpage":"4640","subjects":["chemistry"],"title":"Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitors","type":"article","volume":"35","mendeley_url":"http:\/\/www.mendeley.com\/research\/nonpeptide-fibrinogen-receptor-antagonists-1-discovery-design-exosite-inhibitors"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":3991275,"mean":5.0366419655303,"rank":917037,"this_scored_higher_than_pct":63,"this_scored_higher_than":2528499,"rank_type":"exact","sample_size":3991275,"percentile":63},"similar_age_3m":{"total_number_of_other_articles":124116,"mean":9.01244205234,"rank":37420,"this_scored_higher_than_pct":68,"this_scored_higher_than":85051,"rank_type":"exact","sample_size":124116,"percentile":68},"this_journal":{"total_number_of_other_articles":2923,"mean":3.2200711841205,"rank":570,"this_scored_higher_than_pct":48,"this_scored_higher_than":1419,"rank_type":"exact","sample_size":2923,"percentile":48},"similar_age_this_journal_3m":{"total_number_of_other_articles":79,"mean":3.4877179487179,"rank":19,"this_scored_higher_than_pct":75,"this_scored_higher_than":60,"rank_type":"exact","sample_size":79,"percentile":75}}},"demographics":{"users":{"mendeley":{"by_status":{"Professor > Associate Professor":1,"Researcher":3,"Student  > Ph. D. Student":9,"Student  > Postgraduate":1,"Other":2,"Student  > Master":3,"Student  > Bachelor":1,"Lecturer > Senior Lecturer":1,"Professor":4},"by_discipline":{"Medicine and Dentistry":4,"Chemistry":5,"Agricultural and Biological Sciences":10,"Computer Science":1,"Biochemistry, Genetics and Molecular Biology":2,"Unspecified":1,"Pharmacology, Toxicology and Pharmaceutical Science":2}}},"geo":{"mendeley":{"DE":1,"IN":1}}},"posts":{"wikipedia":[{"title":"Tirofiban","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=258056083#altmetric_citation_3","license":"public","citation_ids":[3358985,3358988],"posted_on":"2008-12-15T04:36:24+00:00","summary":"Aggrastat is indicated to reduce the rate of thrombotic cardiovascular events (combined endpoint of death, myocardial infarction, or refractory ischemia\/repeat cardiac procedure) in patients with non-ST elevation acute coronary syndrome (NSTE-ACS).","page_url":"http:\/\/en.wikipedia.org\/?curid=4269861","wiki_lang":"en","author":{"name":"Citation bot","url":"http:\/\/en.wikipedia.org\/wiki\/User:Citation bot"}}]}}